Correlation Between Verrica Pharmaceuticals and Mereo BioPharma
Can any of the company-specific risk be diversified away by investing in both Verrica Pharmaceuticals and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verrica Pharmaceuticals and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verrica Pharmaceuticals and Mereo BioPharma Group, you can compare the effects of market volatilities on Verrica Pharmaceuticals and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verrica Pharmaceuticals with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verrica Pharmaceuticals and Mereo BioPharma.
Diversification Opportunities for Verrica Pharmaceuticals and Mereo BioPharma
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Verrica and Mereo is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Verrica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verrica Pharmaceuticals are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Verrica Pharmaceuticals i.e., Verrica Pharmaceuticals and Mereo BioPharma go up and down completely randomly.
Pair Corralation between Verrica Pharmaceuticals and Mereo BioPharma
Given the investment horizon of 90 days Verrica Pharmaceuticals is expected to under-perform the Mereo BioPharma. In addition to that, Verrica Pharmaceuticals is 1.39 times more volatile than Mereo BioPharma Group. It trades about -0.04 of its total potential returns per unit of risk. Mereo BioPharma Group is currently generating about 0.07 per unit of volatility. If you would invest 104.00 in Mereo BioPharma Group on November 2, 2024 and sell it today you would earn a total of 201.00 from holding Mereo BioPharma Group or generate 193.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Verrica Pharmaceuticals vs. Mereo BioPharma Group
Performance |
| Timeline |
| Verrica Pharmaceuticals |
| Mereo BioPharma Group |
Verrica Pharmaceuticals and Mereo BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verrica Pharmaceuticals and Mereo BioPharma
The main advantage of trading using opposite Verrica Pharmaceuticals and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verrica Pharmaceuticals position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.| Verrica Pharmaceuticals vs. Inventiva Sa | Verrica Pharmaceuticals vs. Edgewise Therapeutics | Verrica Pharmaceuticals vs. Vigil Neuroscience | Verrica Pharmaceuticals vs. Connect Biopharma Holdings |
| Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |